SHANDONG WIT DYNE HEALTH CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.93 CNY | -1.83% |
|
+1.66% | +20.61% |
| Sales 2024 * | 2.81B 388M | Sales 2025 * | 3.17B 437M | Capitalization | 8.19B 1.13B |
|---|---|---|---|---|---|
| Net income 2024 * | 671M 92.6M | Net income 2025 * | 763M 105M | EV / Sales 2024 * | 2.91 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.58 x |
| P/E ratio 2024 * |
12.2
x | P/E ratio 2025 * |
10.7
x | Employees | 1,763 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.93% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.83% | ||
| 1 week | +1.66% | ||
| Current month | -1.33% | ||
| 1 month | +0.55% | ||
| 3 months | +20.66% | ||
| 6 months | +17.21% | ||
| Current year | +20.61% |
1 week
33.92
35.77
1 month
33.4036.99
Current year
24.0636.99
1 year
24.0639.33
3 years
23.8650.77
5 years
18.0050.77
10 years
11.7059.10
| Managers | Title | Age | Since |
|---|---|---|---|
Jie Yang
CEO | Chief Executive Officer | 63 | 12-05-15 |
Wei Wang
DFI | Director of Finance/CFO | 55 | 21-08-16 |
Da Yu Zhang
BRD | Director/Board Member | 54 | 15-03-11 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhi Yuan Zhang
BRD | Director/Board Member | 61 | 21-08-16 |
Yu Qin Lü
BRD | Director/Board Member | 63 | 20-05-19 |
Jie Yang
CEO | Chief Executive Officer | 63 | 12-05-15 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.15% | 12 M€ | -16.71% | - | |
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 34.93 | -1.83% | 3 320 494 |
| 24-04-25 | 35.58 | +1.08% | 2,357,916 |
| 24-04-24 | 35.2 | +2.59% | 3,650,150 |
| 24-04-23 | 34.31 | -2.80% | 3,424,784 |
| 24-04-22 | 35.3 | +0.34% | 3,404,779 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Shandong WIT Dyne Health Co Ltd, formerly Shandong Shanda Wit Science and Technology Co Ltd, is a China-based company principally engaged in pharmaceutical and environment protection businesses. The Company manufactures and sells pharmaceutical products, food and supplies for children through its subsidiary. Its environment protection business includes the manufacture and sale of chlorine dioxide equipment and products, flue gas desulfurization services for power plants and energy saving services. The Company is also involved in manufacture of electronic information products, owned property rental, education services and new material business, among others.
Sector
Pharmaceuticals
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
34.93
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +20.61% | 1.15B | |
| +26.21% | 653B | |
| +27.00% | 556B | |
| -6.61% | 354B | |
| +20.34% | 331B | |
| +2.65% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.24% | 144B |
- Stock Market
- Equities
- 000915 Stock
